151 related articles for article (PubMed ID: 6090571)
1. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro.
Gillies G; Puri A; Hodgkinson S; Lowry PJ
J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571
[TBL] [Abstract][Full Text] [Related]
2. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami.
Ackland JF; Ratter SJ; Bourne GL; Rees LH
J Endocrinol; 1986 Feb; 108(2):171-80. PubMed ID: 3485168
[TBL] [Abstract][Full Text] [Related]
3. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.
Chowdrey HS; Larsen PJ; Harbuz MS; Jessop DS; Aguilera G; Eckland DJ; Lightman SL
Br J Pharmacol; 1995 Nov; 116(5):2417-24. PubMed ID: 8581278
[TBL] [Abstract][Full Text] [Related]
4. Comparative chromatography of hypothalamic corticotrophin-releasing factors.
Gillies GE; Puri A; Linton EA; Lowry PJ
Neuroendocrinology; 1984 Jan; 38(1):17-24. PubMed ID: 6607424
[TBL] [Abstract][Full Text] [Related]
5. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands.
Dupouy JP; Chatelain A
J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872
[TBL] [Abstract][Full Text] [Related]
6. The influence of vasopressin on hypothalamic corticotrophin releasing activity in rats with inherited diabetes insipidus.
Buckingham JC
J Physiol; 1981 Mar; 312():9-16. PubMed ID: 6973627
[TBL] [Abstract][Full Text] [Related]
7. Ovine corticotropin-releasing factor and vasopressin: antibody-quenching studies on hypothalamic extracts of normal and Brattleboro rats.
Linton EA; Gillies GE; Lowry PJ
Endocrinology; 1983 Nov; 113(5):1878-83. PubMed ID: 6605243
[TBL] [Abstract][Full Text] [Related]
8. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism.
Cambronero JC; Rivas FJ; Borrell J; Guaza C
Eur J Pharmacol; 1992 Aug; 219(1):75-80. PubMed ID: 1327836
[TBL] [Abstract][Full Text] [Related]
9. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro.
Calogero AE; Raiti F; Nicolosi G; Burrello N; D'Agata R; Mantero F
J Endocrinol; 1994 Mar; 140(3):419-24. PubMed ID: 8182369
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.
Buckingham JC
Eur J Pharmacol; 1984 Feb; 98(2):211-21. PubMed ID: 6325216
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of corticotropin-releasing factor and arginine vasopressein in the rat.
Rundle SE; Funder JW
Neuroendocrinology; 1988 May; 47(5):374-8. PubMed ID: 3260999
[TBL] [Abstract][Full Text] [Related]
12. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
Hirotani C; Oki Y; Ukai K; Okuno T; Kurasaki S; Ohyama T; Doi N; Sasaki K; Ase K
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295
[TBL] [Abstract][Full Text] [Related]
13. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K
Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879
[TBL] [Abstract][Full Text] [Related]
14. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
Hillhouse EW; Milton NG
J Endocrinol; 1989 Sep; 122(3):713-8. PubMed ID: 2572662
[TBL] [Abstract][Full Text] [Related]
15. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
16. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of dithiothreitol and iodoacetamide on corticotropin-releasing factor (CRF) activity of bovine hypothalamic CRFs and vasopressin.
Yasuda N; Aizawa T; Greer MA
Endocrinology; 1982 Jun; 110(6):2074-80. PubMed ID: 6280987
[TBL] [Abstract][Full Text] [Related]
18. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
Hillhouse EW; Milton NG
J Endocrinol; 1989 Sep; 122(3):719-23. PubMed ID: 2809479
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny and molecular weight of immunoreactive arginine vasopressin and corticotropin-releasing factor in the ovine fetal hypothalamus.
Saoud CJ; Wood CE
Peptides; 1996; 17(1):55-61. PubMed ID: 8822510
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
Suda T; Yajima F; Tomori N; Demura H; Shizume K
Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
